References
- Wapner R, Thom E, Simpson J L, Pergament E, Silver R, Filkins K, Platt L, Mahoney M, Johnson A, Hogge W A, et al. First-trimester screening for trisomies 21 and 18. N Engl J Med 2003; 349: 1405–1413
- Cleary-Goldman J, Morgan M M, Fergal D M, Robinson J N, D'Alton M E, Schulkin J. Screening for Down syndrome. Practice patterns and knowledge of obstetricians and gynecologists. Obstet Gynecol 2006; 107: 11–17
- Egan J F, Benn P A, Zelop C M, Bolnick A, Gianferrari E, Borgida A F. Down syndrome births in the United States from 1989 to 2001. Am J Obstet Gynecol 2004; 191: 1044–1048
- Kessner D M, Singer J, Kalk C W, Schlesinger E R. Infant death: An analysis by maternal risk and health care. Contrasts in Health Status. Institute of Medicine, National Academy of Sciences, Washington, DC 1973; 1: 50–95
- Kotelchuck M. An evaluation of the Kessner Adequacy of Prenatal Care Index and a proposed Adequacy of Prenatal Care Utilization Index. Am J Public Health 1994; 84: 1414–1420
- National Center for Health Statistics. Natality data set. Centers for Disease Control and Prevention, Atlanta 1997–2002, CD-ROM, series 21
- National Center for Health Statistics. Hospitals' and physicians' handbook on birth registration and fetal death reporting. Public Health Service, Washington, DC 1987
- Gortmaker S L. The effects of prenatal care upon the health of the newborn. Am J Public Health 1979; 69: 653–660
- Bray I, Wright D E, Davies C, Hook E B. Joint estimation of Down syndrome risk and ascertainment rates: A meta-analysis of nine published data sets. Prenat Diagn 1998; 18: 9–20
- Egan J F, Benn P, Brogida A, Rodis J, Campbell W, Vintzileos A. Efficacy of screening for fetal Down syndrome in the United States from 1974 to 1997. Obstet Gynecol 2000; 96: 979–985
- Benn P A, Ying J, Beazoglou T, Egan J F. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results. Prenat Diagn 2001; 21: 46–51
- Crane J P, Gray D L. Sonographically measured nuchal skinfold thickness as a screening tool for Down syndrome. Obstet Gynecol 1991; 77: 533–536
- Smith-Bindman R, Hosmer W, Feldstein V A, Deeks J J, Goldberg J D. Second-trimester ultrasound to detect fetuses with Down syndrome: A meta-analysis. JAMA 2001; 285: 1044–1055
- Watkins M L, Edmonds L, McClearn A, Mullins L, Mulinare J, Khoury M. The surveillance of birth defects: The usefulness of the revised US standard birth certificate. Am J Public Health 1996; 86: 731–734
- Babak Khoshnood B, Blondel B, De Vigan C, MD, Bréart G. Socioeconomic barriers to informed decision making regarding maternal serum screening for Down syndrome: Results of the French National Perinatal Survey of 1998. Am J Public Health 2004; 94: 484–491
- Khoshnood B, Pryde P, Blondel B, Lee K S. Socioeconomic and state-level differences in prenatal diagnosis and live birth prevalence of Down's syndrome in the United States. Rev Epidemiol Sante Publique 2003; 51: 628–630
- Kupperman M, Gates E, Washington A E. Racial-ethnic differences in prenatal diagnostic test use and outcomes: Preferences, socioeconomics, or patient knowledge?. Obstet Gynecol 1996; 87: 675–682